Evidence map›Paper›PMID 37225825›Full record

ArticleEye (London, England)2023

Is an image-based eyelid management service safe and effective?

Matthew Gillam, Osman Younus, Shi-Pei Loo, Julie Connolly, Paul Cauchi, Marilena Gregory, Suzy Drummond, Vikas Chadha

Open access · hybridAbstract read
In one paragraph

Article in Eye (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Matthew GillamChelsea and Westminster Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0001-8503-600X
Osman YounusNHS Greater Glasgow and Clyde, Glasgow, UK.ORCID 0000-0003-1677-5284
Shi-Pei LooNHS Greater Glasgow and Clyde, Glasgow, UK.
Julie ConnollyNHS Greater Glasgow and Clyde, Glasgow, UK.
Paul CauchiNHS Greater Glasgow and Clyde, Glasgow, UK.ORCID 0000-0002-7881-0922
Marilena GregoryNHS Greater Glasgow and Clyde, Glasgow, UK.
Suzy DrummondNHS Greater Glasgow and Clyde, Glasgow, UK.
Vikas ChadhaNHS Greater Glasgow and Clyde, Glasgow, UK. vikas.chadha@ggc.scot.nhs.uk.
NHS Greater Glasgow and Clyde · GBChelsea and Westminster Hospital NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic created a requirement for reduced patient contact and reduced capacity in clinics. We previously published results of an Image-Based Eyelid Lesion Management Service (IBELMS) which was found non-inferior to traditional face-to-face clinic at diagnosing lesions and identifying eyelid malignancies. We now present first-year safety and efficacy data from this service.

methodsData were collected retrospectively on all patients seen in NHS Greater Glasgow and Clyde eyelid photography clinics from 30

results808 patients were included in the study. Chalazion was the most common diagnoses recorded (38.4%). There was a statistically significant decrease in mean time from referral to appointment time between the first 4 months and last 4 months of the service (93 days to 22 days, p ≤ 0.0001). 266 (33%) of patients were discharged following photographs, 45 (6%) were discharged for non-attendance and 371 (46%) were booked for a minor procedure. 13 biopsy-confirmed malignant lesions were identified; only 3 had been referred as suspected malignancy. 23 patients out of 330 with at least 6 months follow up (7%) were re-referred within 6 months of treatment or discharge; however, none of them with a missed periocular malignancy. DISCUSSION: Eyelid photography clinics effectively reduce patient waiting times and maximise clinic capacity. They accurately identify eyelid lesions including malignancies with a low re-referral rate. We propose that an image-based service for eyelid lesions is a safe and effective way of managing such patients.

Indexed as

Eyelid NeoplasmsSkin NeoplasmsEyelidsHumansPandemicsRetrospective Studies

Identifiers

PMID37225825
PMCPMC10206336
OpenAlexW4377942619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.